Allopurinol Hypersensitivity Syndrome Associated With Pancreatic Exocrine Abnormalities and New-Onset Diabetes Mellitus
- 27 May 2002
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (10) , 1190-1192
- https://doi.org/10.1001/archinte.162.10.1190
Abstract
Allopurinol, a xanthine oxidase inhibitor, has been in use since 1963 as an effective treatment to lower uric acid levels in patients with gout. Severe and occaThis publication has 10 references indexed in Scilit:
- A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related AntibodiesNew England Journal of Medicine, 2000
- The allopurinol hypersensitivity syndromeThe Netherlands Journal of Medicine, 1998
- Drug induced acute pancreatitis: incidence and severity.Gut, 1995
- Differing Frequency of Autoantibodies to Glutamic Acid Decarboxylase among Koreans, Thais, and Australians with Diabetes MellitusClinical Immunology and Immunopathology, 1995
- Allopurinol Hypersensitivity Syndrome: A ReviewAnnals of Pharmacotherapy, 1993
- Does Pan-Pancreatic Involvement Occur in IDDM?Diabetes Care, 1988
- The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortalityArthritis & Rheumatism, 1986
- Severe Allopurinol Toxicity. Description and Guidelines for Prevention in Patients With Renal InsufficiencyJournal of Urology, 1984
- Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromiseArchives of internal medicine (1960), 1974
- Vasculitis with allopurinol therapyAmerican Heart Journal, 1970